OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment
Juanni Li, Kuan Hu, Jinzhou Huang, et al.
Aging (2021) Vol. 13, Iss. 12, pp. 16541-16566
Open Access | Times Cited: 8
Juanni Li, Kuan Hu, Jinzhou Huang, et al.
Aging (2021) Vol. 13, Iss. 12, pp. 16541-16566
Open Access | Times Cited: 8
Showing 8 citing articles:
Targeting FGFR for cancer therapy
Pei Zhang, Lin Yue, Qingqing Leng, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 13
Pei Zhang, Lin Yue, Qingqing Leng, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 13
An intuitionistic approach for the predictability of anti-angiogenic inhibitors in cancer diagnosis
Syed Anas Ansar, Shruti Aggarwal, Swati Arya, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 21
Syed Anas Ansar, Shruti Aggarwal, Swati Arya, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 21
FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies
Maxim Noeraparast, Katarina Krajina, Renate Pichler, et al.
Cancer Communications (2024) Vol. 44, Iss. 10, pp. 1189-1208
Open Access | Times Cited: 2
Maxim Noeraparast, Katarina Krajina, Renate Pichler, et al.
Cancer Communications (2024) Vol. 44, Iss. 10, pp. 1189-1208
Open Access | Times Cited: 2
Diffusely invasive supratentorial rosette-forming glioneuronal tumor: illustrative case
Brittany Owusu‐Adjei, Constance J. Mietus, Jeewoo Chelsea Lim, et al.
Journal of Neurosurgery Case Lessons (2023) Vol. 6, Iss. 16
Open Access | Times Cited: 5
Brittany Owusu‐Adjei, Constance J. Mietus, Jeewoo Chelsea Lim, et al.
Journal of Neurosurgery Case Lessons (2023) Vol. 6, Iss. 16
Open Access | Times Cited: 5
Case Report: Anlotinib Reverses Nivolumab Resistance in Advanced Primary Pulmonary Lymphoepithelioma-Like Carcinoma With FGFR3 Gene Amplification
Yanyang Liu, Lang Long, Jiewei Liu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 7
Yanyang Liu, Lang Long, Jiewei Liu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 7
Case Report: Targeted Therapy with Anlotinib for a Rare Case of Spinal Cord Glioblastoma with FGFR3 Mutation
Ruiqiong Liu, Wei Wei, Huaying Hou, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 771-776
Open Access | Times Cited: 4
Ruiqiong Liu, Wei Wei, Huaying Hou, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 771-776
Open Access | Times Cited: 4
Replenishing co‐downregulated miR ‐100‐5p and miR ‐125b‐5p in malignant germ cell tumors causes growth inhibition through cell cycle disruption
Marta Ferraresso, Shivani Bailey, Luz Alonso‐Crisostomo, et al.
Molecular Oncology (2024)
Open Access
Marta Ferraresso, Shivani Bailey, Luz Alonso‐Crisostomo, et al.
Molecular Oncology (2024)
Open Access
ELL associated factor 2 is a potential diagnostic and prognostic indicator: evidence from the in silico and in vitro experiments.
Xiao Yu, Jing-Quan Teng, Jia Chen, et al.
PubMed (2023) Vol. 13, Iss. 6, pp. 2572-2587
Closed Access
Xiao Yu, Jing-Quan Teng, Jia Chen, et al.
PubMed (2023) Vol. 13, Iss. 6, pp. 2572-2587
Closed Access
